SpecSpace is not a conventional real estate play. It is the physical extension of CleanSpace’s vertically integrated model, where design, engineering, manufacturing, construction and CQV operate as a single coordinated system. SpecSpace extends the CleanSpace platform into commercial real estate by aligning site selection, facility strategy, and development expertise with the unique requirements of regulated and advanced manufacturing clients. SpecSpace delivers fully compliant buildings by aligning real estate strategy with regulatory, operational, and facility requirements from the outset. This ensures clients secure spaces that are not only suitable for regulated environments, but ready for validation, compliance and operational readiness and performance from day one.
“SpecSpace fundamentally changes how life sciences companies access and activate critical environments,” said Glenn VandeGrift, President of CleanSpace. “We are removing friction from the process and replacing it with a model built on certainty, speed, and performance. This is about giving our clients a competitive advantage when time and compliance are non-negotiable.”
SpecSpace delivers purpose-built facilities designed specifically for the demands of life sciences and biotechnology. Focused on speed, compliance, and operational readiness, each environment is cGMP-aligned and engineered to support immediate use, eliminating the delays and uncertainty associated with traditional ground-up development or retrofit conversions.
The inaugural Doylestown campus is a state-of-the-art manufacturing facility paired with a Class A office environment, strategically located within the Greater Philadelphia life sciences corridor near Pennsylvania Biotechnology Center and Cellicon Valley. Purposefully designed for CDMOs and life sciences leaders, the campus can be tailored through CleanSpace’s modern design-build approach to meet specific operational and regulatory requirements.
“Speed to cGMP production is no longer a competitive edge, it is a requirement,” said George Wiker, CEO. “SpecSpace gives companies a direct path from site selection to operational readiness without the traditional gaps between real estate, design, and execution. We are delivering facilities that are ready to perform on day one and built to scale for what comes next.”
By aligning real estate with execution, SpecSpace enables organisations to move from site selection to cGMP production faster, with facilities designed to meet current regulatory expectations and future growth demands.
